Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis
Kumar V, Kumar V, Luo J, Mahato RI. Mol Ther. 2018 Dec 5;26(12):2798-2811. PubMed
Phenotypic miRNA Screen Identifies miR-26b to Promote the Growth and Survival of Endothelial Cells
Martello A, Mellis D, Meloni M, Howarth A, Ebner D, Caporali A, Al Haj Zen A. Mol Ther Nucleic Acids. 2018 Dec 7;13:29-43. PubMed
Inhibition of miR-449a Promotes Cartilage Regeneration and Prevents Progression of Osteoarthritis in In Vivo Rat Models
Baek D, Lee KM, Park KW, Suh JW, Choi SM, Park KH, Lee JW, Kim SH. Mol Ther Nucleic Acids. 2018 Dec 7;13:322-333. PubMed
Enhanced Tailored MicroRNA Sponge Activity of RNA Pol II-Transcribed TuD Hairpins Relative to Ectopically Expressed ciRS7-Derived circRNAs
Hollensen AK, Andersen S, Hjorth K, Bak RO, Hansen TB, Kjems J, Aagaard L, Damgaard CK, Mikkelsen JG. Mol Ther Nucleic Acids. 2018 Dec 7;13:365-375. PubMed
The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein
Kim T, Mehta SL, Morris-Blanco KC, Chokkalla AK, Chelluboina B, Lopez M, Sullivan R, Kim HT, Cook TD, Kim JY, Kim H, Kim C, Vemuganti R. Sci Signal. 2018 Dec 11;11(560). pii: eaat4285. PubMed
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Hu N, Antoury L, Baran TM, Mitra S, Bennett CF, Rigo F, Foster TH, Wheeler TM. Nat Commun. 2018 Dec 7;9(1):5227. PubMed
NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
Watanabe N, Nagata T, Satou Y, Masuda S, Saito T, Kitagawa H, Komaki H, Takagaki K, Takeda S. Mol Ther Nucleic Acids. 2018 Dec 7;13:442-449. PubMed
Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity
O'Reilly D, Kartje ZJ, Ageely EA, Malek-Adamian E, Habibian M, Schofield A, Barkau CL, Rohilla KJ, DeRossett LB, Weigle AT, Damha MJ, Gagnon KT. Nucleic Acids Res. 2018 Dec 4. PubMed
Predictable and precise template-free CRISPR editing of pathogenic variants
Shen MW, Arbab M, Hsu JY, Worstell D, Culbertson SJ, Krabbe O, Cassa CA, Liu DR, Gifford DK, Sherwood RI. Nature. 2018 Nov;563(7733):646-651. PubMed
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing
Li B, Zeng C, Li W, Zhang X, Luo X, Zhao W, Zhang C, Dong Y. Cell Rep. 2018 Dec 18;25(12):3262-3272.e3. PubMed